Loading...
Domestic
Equity
Passive

KBSTAR Healthcare (253280)

Update : 2022.07.07

NAV

11,404KRW

-27.29하락 (-0.24%)

Market Price per share (KRW)

11,375KRW

-55하락 (-0.48%)

※ t-1 last price

trading volume

1,121shares

AUM

KRW 5.7billion

KBSTAR Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2022.07.07
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB KStar V&S Select ValueETF(Equity)
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 5,701,876,925
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 11,375
※ t-1 last price
11,403 1,121
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB KStar V&S Select ValueETF(Equity)

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
5,701,876,925 하나은행
Market Price per share (KRW) iNAV per share (KRW)
11,375
※ t-1 last price
11,403
Trading Volume (shares)
1,121
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2022-07-07
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion Healthcare 11.59
2 Celltrion 11.38
3 SAMSUNG BIOLOGICS 9.96
4 HLB 6.74
5 Yuhan 5.77
6 SKBS 5.11
7 HanmiPharm 4.62
8 SKBP 4.10
9 SD Biosensor 3.08
10 SEEGENE 2.84

proportion by sectors

Update : 2022.07.07
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2019-04-30 2019-05-02 10
2020-04-29 2020-05-06 46
2021-04-30 2021-05-04 71
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2022-07-07

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -3.68 -7.22 -13.84 -31.66 18.86 -19.39 12.11
Benchmark Index -3.78 -7.77 -13.65 -31.67 19.22 -19.26 13.28
Outperformance 0.09 0.54 -0.19 0.01 -0.36 -0.13 -1.17

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2022.07.06 11,375 -0.481하락 11,431.04 4.547상승
2022.07.05 11,430 4.526상승 10,933.81 1.302상승
2022.07.04 10,935 1.579상승 10,793.21 -
2022.07.01 10,765 -2.002하락 10,980.24 0.375상승
2022.06.30 10,985 0.319상승 10,939.2 -0.869하락
2022.06.29 10,950 -0.544하락 11,035.1 0.241상승
2022.06.28 11,010 - 11,008.56 0.638상승
2022.06.27 11,010 0.685상승 10,938.69 -
2022.06.24 10,935 5.754상승 10,348.41 -1.231하락
2022.06.23 10,340 -1.429하락 10,477.4 -1.542하락
2022.06.22 10,490 -1.456하락 10,641.55 2.014상승
2022.06.21 10,645 1.963상승 10,431.42 -2.052하락
2022.06.20 10,440 -1.089하락 10,649.97 -
2022.06.17 10,555 -0.283하락 10,579.53 -0.508하락
2022.06.16 10,585 -0.470하락 10,633.57 -2.239하락
2022.06.15 10,635 -2.116하락 10,877.19 -0.933하락
2022.06.14 10,865 -0.730하락 10,979.73 -4.039하락
2022.06.13 10,945 -4.368하락 11,441.94 -
2022.06.10 11,445 -1.633하락 11,678.78 0.363상승
2022.06.09 11,635 -0.042하락 11,636.47 0.797상승
2022.06.08 11,640 0.735상승 11,544.4 -2.495하락

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares
/ Par value
Weight(%) Market price (KRW)
1 Celltrion Healthcare KR7091990002 910 11.59 72,600
2 Celltrion KR7068270008 348 11.38 186,500
3 SAMSUNG BIOLOGICS KR7207940008 71 9.96 800,000
4 HLB KR7028300002 1,075 6.74 35,750
5 Yuhan KR7000100008 576 5.77 57,100
6 SKBS KR7302440003 240 5.11 121,500
7 HanmiPharm KR7128940004 83 4.62 317,500
8 SKBP KR7326030004 308 4.1 75,900
9 SD Biosensor KR7137310009 406 3.08 43,300
10 SEEGENE KR7096530001 411 2.84 39,400
11 Celltrionph KR7068760008 196 2.82 81,900
12 GC Corp KR7006280002 62 1.85 170,000
13 ST Pharm KR7237690003 113 1.84 92,700
14 Hanmi Science KR7008930000 254 1.81 40,550
15 Hugel KR7145020004 97 1.8 105,700
16 원화예금 KRD010010001 9,642,722 1.69 -
17 DAEWOONG PHARM KR7069620003 51 1.59 177,500
18 HANALL BIOPHARMA KR7009420001 399 1.18 16,900
19 CHA Biotech KR7085660009 449 1.15 14,600
20 BIONEER KR7064550007 251 1.12 25,450
21 DENTIUM KR7145720009 74 1.12 86,300
22 HK inno.N KR7195940002 164 1.12 38,850
23 HUMASIS KR7205470008 360 1.09 17,300
24 MedyTox KR7086900008 55 1.09 112,500
25 BukwangPharm KR7003000007 698 1.05 8,600
26 GC CELL KR7144510005 90 0.93 58,700
27 ILDONG PHARM KR7249420001 183 0.92 28,750
28 SCD KR7000250001 153 0.86 32,150
29 GCH Corp KR7005250006 245 0.84 19,650
30 Binex KR7053030003 316 0.83 14,900
31 PharmaResearch KR7214450009 68 0.79 65,900
32 Amicogen KR7092040005 183 0.76 23,600
33 Lutronic KR7085370005 234 0.74 18,150
34 Jeisys Medical KR7287410005 561 0.71 7,240
35 YUNGJIN PHARM KR7003520004 1,015 0.62 3,500
36 JWPHARMA KR7001060003 144 0.6 23,600
37 IlyangPharm KR7007570005 152 0.6 22,500
38 CLASSYS KR7214150005 195 0.49 14,400
39 DIO KR7039840004 104 0.47 25,800
40 VATECH KR7043150002 79 0.42 30,550
41 Boditech KR7206640005 201 0.42 12,050
42 KUP KR7033270000 101 0.4 22,450
43 DongwhaPharm KR7000020008 194 0.35 10,350
44 REYON KR7102460003 81 0.32 22,550
45 UBCARE KR7032620007 272 0.25 5,290
46 KOREA PHARMA KR7032300006 38 0.16 24,350
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.